Pulmonary Function Testing Systems Market Synopsis
Pulmonary Function Testing Systems Market Size Was Valued at USD 141.8 Million in 2023, and is Projected to Reach USD 282.99 Million by 2032, Growing at a CAGR of 7.98% From 2024-2032.
Pulmonary function tests are non-invasive tests that determine how well the lungs work. The tests measure lung volume, gas exchange, and rates of flow. This test helps physicians and healthcare workers to diagnose and decide the treatment of lung disorders.
- Lungs perform the function of the pulmonary. This involves breathing in air through the nasal passages leading to the lungs and taking in oxygen from the blood that travels to other parts of the body and exhaling carbon dioxide as waste through the nasal passages.
- People are given a number of tests to check how well their lungs are working. These are done with pulmonary function testing equipment. Tests can be done for two reasons. First, if the airway is blocked or obstructed. Second, when the absorption of oxygen in the blood is limited or reduced.
- The key manufacturers of pulmonary function testing systems are focused on partnership, acquisition, and collaboration to boost market growth. For instance, add Medical Technologies announced its new partnership with Biomedix, a provider of front-line diagnostic solutions for delivering value-based care. Biomedix offers various platforms that centralize data for analyzing population health across multiple chronic conditions, including COPD.
The Pulmonary Function Testing Systems Market Trend Analysis
Increasing Prevalence of The Lung-Related Disorder
- The increasing prevalence of lung cancer and lung-related disorders boosts the market growth. For instance, according to world cancer research world fund international, lung cancer is the second-most common cancer around the world. There were more than 2.2 million new cases of lung cancer in 2020. Moreover, an increase in air pollution which leads to breathing problems drives the market growth.
- Smoking and drinking habits cause lung cancer so the demand for pulmonary function equipment is increasing and it’s a major factor that drives the market growth. For instance, according to Statista, the age-standardized incidence rate of lung cancer among males around the world was 31.5 per 100,000 population. In 2020 the incidence rate of lung cancer among males was highest in Polynesia.
- The growing demand for minimally invasive tests to design an appropriate method of lung testing disease and increasing in the rate of mortality boosts the market growth in the upcoming years. Additionally, the increase in the geriatric population and people's awareness is also driving the demand for portable lung function testing devices as they can be easily used in home healthcare.
Technological Advancement and Innovation in Technology
- The excessive consumption of tobacco in the form of cigarettes and the use of this test to ensure lung health and the infection-free nature of the body's airways are driving the growth of the pulmonary function testing market.
- As awareness of the systematic examination of a patient's lung health through chest x-rays, physical tests, arterial blood gas analysis, and examination of the patient's habits and medical history has increased, so has a concern about lung damage that can affect normal lung function. Life and the need to limit their impact and severity are also influencing the pulmonary function testing market. In addition, improvements in healthcare infrastructure, growth in research and development, and growth in healthcare costs are positively affecting the pulmonary function testing market growth.
- Technological advancements and technological innovations will create more growth opportunities for pulmonary function testing system market players during the forecast period. Life expectancy has increased, which means that there are a large number of elderly people who need medical care. Diseases such as lung cancer, pulmonary congestion, and asthma are more common in the elderly. Such factors provide additional growth opportunities for the market.
Segmentation Analysis of The Pulmonary Function Testing Systems Market
Pulmonary Function Testing Systems market segments cover the Type, Test, Application, and End User. By End Users, the hospital segment is anticipated to dominate the Market Over the Forecast period.
- The segmental growth is the result of an increase in the number of patients with COPD and asthma visiting hospitals. Moreover, the segment is anticipated to rise in the upcoming years due to hospitals' increasing usage of comprehensive systems for patient diagnosis. The category for physician groups is anticipated to grow fast throughout the forecast period.
- The rise in the prevalence of chronic respiratory disorders, the increased focus of market leaders on developing portable systems for hospitals, and an increase in the use of these systems in clinics are all factors that drive the segment's growth. For instance, in August 2019, Ruby Hall in Pune, India, announced the installation of the CareFusion-produced Vyntus Body pulmonary function test system. Moreover, the increased number of patients visiting hospitals for the diagnosis of lung disorders boosts the market growth in the upcoming years.
Regional Analysis of The Pulmonary Function Testing Systems Market
North America is Expected to Dominate the Pulmonary Function Testing Systems Market Over the Forecast period.
- In North America advanced medical infrastructure and the high disposable income of consumers increase the growth in pulmonary function testing systems can boost the market growth. In this region well, developed healthcare infrastructure as well as the rising prevalence of pulmonary disorders and respiratory diseases drives the market growth in this region.
- North America due to increasing research and development facilities for approval and development of novel drug therapies as well as rising demand for advanced medical devices for treatment boosts the market growth. Various government policies support the purchase of advanced pulmonary function testing and increasing genetic diseases boost the market growth. Also, technologically advanced products offering more features in function testing systems are the driving factor in this region. Additionally, an increase in the per capita healthcare expenditure with increasing hospital admissions drives the growth of the pulmonary function testing system market in this region in the upcoming years.
Top Key Players Covered in The Pulmonary Function Testing Systems Market
- MGC Diagnostics Corporation (US)
- Morgan Scientific Inc. (US)
- Omron Healthcare Inc(Japan)
- Cosmed Srl (Italy)
- Ganshorn Medizin Electronic (Germany)
- ndd Medizintechnik AG (Switzerland)
- Schiller AG (Switzerland)
- Vyaire Medical, Inc (US)
- Minato Holdings Inc. (Japan)
- Eco Medics Ag (Switzerland)
- Chest M.I., Inc (Japan)
- Koninklijke Philips N.V. (Netherlands)
- PulmOne Advanced Medical Devices (Israel)
- KoKo PFT (US), and Other Major Players.
Key Industry Developments in the Pulmonary Function Testing Systems Market
- In March 2023, Vitalograph, a respiratory diagnostic devices manufacturer, announced the launch of the VitaloPFT Pulmonary Function Testing Series at the annual Arab Health Exhibition in Dubai. The product was launched with an aim for use in secondary care.
- January 2023, CAIRE Inc., a subsidiary of NGK SPARK PLUG CO., LTD., expanded its expertise in pulmonary disease by acquiring MGC Diagnostics Corporation. The acquisition allowed CAIRE to strengthen its position in the respiratory care market. This strategic move aligned with the company's goal to enhance its product offerings and provide advanced solutions for diagnosing and treating pulmonary conditions.
Global Pulmonary Function Testing Systems Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 141.8 Mn. |
Forecast Period 2024-32 CAGR: |
7.98% |
Market Size in 2032: |
USD 282.99 Mn. |
Segments Covered: |
By Type |
|
|
By Test |
|
||
By Application |
|
||
By End-Users |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Test
3.3 By Application
3.4 By End Users
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Pulmonary Function Testing Systems Market by Type
5.1 Pulmonary Function Testing Systems Market Overview Snapshot and Growth Engine
5.2 Pulmonary Function Testing Systems Market Overview
5.3 Portable PFT Systems
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size ( 2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Portable PFT Systems: Geographic Segmentation
5.4 Complete PFT Systems
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size ( 2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Complete PFT Systems: Geographic Segmentation
Chapter 6: Pulmonary Function Testing Systems Market by Test
6.1 Pulmonary Function Testing Systems Market Overview Snapshot and Growth Engine
6.2 Pulmonary Function Testing Systems Market Overview
6.3 Gas Exchange Testing
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size ( 2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Gas Exchange Testing: Geographic Segmentation
6.4 Oxygen Titration Test
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size ( 2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Oxygen Titration Test: Geographic Segmentation
6.5 Spirometry
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size ( 2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Spirometry: Geographic Segmentation
6.6 Lung Volume
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size ( 2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Lung Volume: Geographic Segmentation
6.7 Others
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size ( 2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Others: Geographic Segmentation
Chapter 7: Pulmonary Function Testing Systems Market by Application
7.1 Pulmonary Function Testing Systems Market Overview Snapshot and Growth Engine
7.2 Pulmonary Function Testing Systems Market Overview
7.3 Restrictive Lung Disease
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size ( 2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Restrictive Lung Disease: Geographic Segmentation
7.4 Chronic Obstructive Pulmonary Disease
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size ( 2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Chronic Obstructive Pulmonary Disease: Geographic Segmentation
7.5 Asthma
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size ( 2017-2032F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Asthma: Geographic Segmentation
7.6 Other
7.6.1 Introduction and Market Overview
7.6.2 Historic and Forecasted Market Size ( 2017-2032F)
7.6.3 Key Market Trends, Growth Factors and Opportunities
7.6.4 Other: Geographic Segmentation
Chapter 8: Pulmonary Function Testing Systems Market by End Users
8.1 Pulmonary Function Testing Systems Market Overview Snapshot and Growth Engine
8.2 Pulmonary Function Testing Systems Market Overview
8.3 Hospitals
8.3.1 Introduction and Market Overview
8.3.2 Historic and Forecasted Market Size ( 2017-2032F)
8.3.3 Key Market Trends, Growth Factors and Opportunities
8.3.4 Hospitals: Geographic Segmentation
8.4 Clinical Laboratories
8.4.1 Introduction and Market Overview
8.4.2 Historic and Forecasted Market Size ( 2017-2032F)
8.4.3 Key Market Trends, Growth Factors and Opportunities
8.4.4 Clinical Laboratories: Geographic Segmentation
8.5 Diagnostics Laboratories
8.5.1 Introduction and Market Overview
8.5.2 Historic and Forecasted Market Size ( 2017-2032F)
8.5.3 Key Market Trends, Growth Factors and Opportunities
8.5.4 Diagnostics Laboratories: Geographic Segmentation
8.6 Other
8.6.1 Introduction and Market Overview
8.6.2 Historic and Forecasted Market Size ( 2017-2032F)
8.6.3 Key Market Trends, Growth Factors and Opportunities
8.6.4 Other: Geographic Segmentation
Chapter 9: Company Profiles and Competitive Analysis
9.1 Competitive Landscape
9.1.1 Competitive Positioning
9.1.2 Pulmonary Function Testing Systems Sales and Market Share By Players
9.1.3 Industry BCG Matrix
9.1.4 Heat Map Analysis
9.1.5 Pulmonary Function Testing Systems Industry Concentration Ratio (CR5 and HHI)
9.1.6 Top 5 Pulmonary Function Testing Systems Players Market Share
9.1.7 Mergers and Acquisitions
9.1.8 Business Strategies By Top Players
9.2 MGC DIAGNOSTICS CORPORATION
9.2.1 Company Overview
9.2.2 Key Executives
9.2.3 Company Snapshot
9.2.4 Operating Business Segments
9.2.5 Product Portfolio
9.2.6 Business Performance
9.2.7 Key Strategic Moves and Recent Developments
9.2.8 SWOT Analysis
9.3 MORGAN SCIENTIFIC INC.
9.4 OMRON HEALTHCARE INC
9.5 COSMED SRL
9.6 GANSHORN MEDIZIN ELECTRONIC
9.7 NDD MEDIZINTECHNIK AG
9.8 SCHILLER AG
9.9 VYAIRE MEDICAL INC
9.10 MINATO HOLDINGS INC.
9.11 ECO MEDICS AG
9.12 CHEST M.I. INC
9.13 KONINKLIJKE PHILIPS N.V.
9.14 PULMONE ADVANCED MEDICAL DEVICES
9.15 KOKO PFT
9.16 OTHER MAJOR PLAYERS
Chapter 10: Global Pulmonary Function Testing Systems Market Analysis, Insights and Forecast, 2017-2032
10.1 Market Overview
10.2 Historic and Forecasted Market Size By Type
10.2.1 Portable PFT Systems
10.2.2 Complete PFT Systems
10.3 Historic and Forecasted Market Size By Test
10.3.1 Gas Exchange Testing
10.3.2 Oxygen Titration Test
10.3.3 Spirometry
10.3.4 Lung Volume
10.3.5 Others
10.4 Historic and Forecasted Market Size By Application
10.4.1 Restrictive Lung Disease
10.4.2 Chronic Obstructive Pulmonary Disease
10.4.3 Asthma
10.4.4 Other
10.5 Historic and Forecasted Market Size By End Users
10.5.1 Hospitals
10.5.2 Clinical Laboratories
10.5.3 Diagnostics Laboratories
10.5.4 Other
Chapter 11: North America Pulmonary Function Testing Systems Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Portable PFT Systems
11.4.2 Complete PFT Systems
11.5 Historic and Forecasted Market Size By Test
11.5.1 Gas Exchange Testing
11.5.2 Oxygen Titration Test
11.5.3 Spirometry
11.5.4 Lung Volume
11.5.5 Others
11.6 Historic and Forecasted Market Size By Application
11.6.1 Restrictive Lung Disease
11.6.2 Chronic Obstructive Pulmonary Disease
11.6.3 Asthma
11.6.4 Other
11.7 Historic and Forecasted Market Size By End Users
11.7.1 Hospitals
11.7.2 Clinical Laboratories
11.7.3 Diagnostics Laboratories
11.7.4 Other
11.8 Historic and Forecast Market Size by Country
11.8.1 U.S.
11.8.2 Canada
11.8.3 Mexico
Chapter 12: Europe Pulmonary Function Testing Systems Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Portable PFT Systems
12.4.2 Complete PFT Systems
12.5 Historic and Forecasted Market Size By Test
12.5.1 Gas Exchange Testing
12.5.2 Oxygen Titration Test
12.5.3 Spirometry
12.5.4 Lung Volume
12.5.5 Others
12.6 Historic and Forecasted Market Size By Application
12.6.1 Restrictive Lung Disease
12.6.2 Chronic Obstructive Pulmonary Disease
12.6.3 Asthma
12.6.4 Other
12.7 Historic and Forecasted Market Size By End Users
12.7.1 Hospitals
12.7.2 Clinical Laboratories
12.7.3 Diagnostics Laboratories
12.7.4 Other
12.8 Historic and Forecast Market Size by Country
12.8.1 Germany
12.8.2 U.K.
12.8.3 France
12.8.4 Italy
12.8.5 Russia
12.8.6 Spain
12.8.7 Rest of Europe
Chapter 13: Asia-Pacific Pulmonary Function Testing Systems Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Portable PFT Systems
13.4.2 Complete PFT Systems
13.5 Historic and Forecasted Market Size By Test
13.5.1 Gas Exchange Testing
13.5.2 Oxygen Titration Test
13.5.3 Spirometry
13.5.4 Lung Volume
13.5.5 Others
13.6 Historic and Forecasted Market Size By Application
13.6.1 Restrictive Lung Disease
13.6.2 Chronic Obstructive Pulmonary Disease
13.6.3 Asthma
13.6.4 Other
13.7 Historic and Forecasted Market Size By End Users
13.7.1 Hospitals
13.7.2 Clinical Laboratories
13.7.3 Diagnostics Laboratories
13.7.4 Other
13.8 Historic and Forecast Market Size by Country
13.8.1 China
13.8.2 India
13.8.3 Japan
13.8.4 Singapore
13.8.5 Australia
13.8.6 New Zealand
13.8.7 Rest of APAC
Chapter 14: Middle East & Africa Pulmonary Function Testing Systems Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Portable PFT Systems
14.4.2 Complete PFT Systems
14.5 Historic and Forecasted Market Size By Test
14.5.1 Gas Exchange Testing
14.5.2 Oxygen Titration Test
14.5.3 Spirometry
14.5.4 Lung Volume
14.5.5 Others
14.6 Historic and Forecasted Market Size By Application
14.6.1 Restrictive Lung Disease
14.6.2 Chronic Obstructive Pulmonary Disease
14.6.3 Asthma
14.6.4 Other
14.7 Historic and Forecasted Market Size By End Users
14.7.1 Hospitals
14.7.2 Clinical Laboratories
14.7.3 Diagnostics Laboratories
14.7.4 Other
14.8 Historic and Forecast Market Size by Country
14.8.1 Turkey
14.8.2 Saudi Arabia
14.8.3 Iran
14.8.4 UAE
14.8.5 Africa
14.8.6 Rest of MEA
Chapter 15: South America Pulmonary Function Testing Systems Market Analysis, Insights and Forecast, 2017-2032
15.1 Key Market Trends, Growth Factors and Opportunities
15.2 Impact of Covid-19
15.3 Key Players
15.4 Key Market Trends, Growth Factors and Opportunities
15.4 Historic and Forecasted Market Size By Type
15.4.1 Portable PFT Systems
15.4.2 Complete PFT Systems
15.5 Historic and Forecasted Market Size By Test
15.5.1 Gas Exchange Testing
15.5.2 Oxygen Titration Test
15.5.3 Spirometry
15.5.4 Lung Volume
15.5.5 Others
15.6 Historic and Forecasted Market Size By Application
15.6.1 Restrictive Lung Disease
15.6.2 Chronic Obstructive Pulmonary Disease
15.6.3 Asthma
15.6.4 Other
15.7 Historic and Forecasted Market Size By End Users
15.7.1 Hospitals
15.7.2 Clinical Laboratories
15.7.3 Diagnostics Laboratories
15.7.4 Other
15.8 Historic and Forecast Market Size by Country
15.8.1 Brazil
15.8.2 Argentina
15.8.3 Rest of SA
Chapter 16 Investment Analysis
Chapter 17 Analyst Viewpoint and Conclusion
Global Pulmonary Function Testing Systems Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 141.8 Mn. |
Forecast Period 2024-32 CAGR: |
7.98% |
Market Size in 2032: |
USD 282.99 Mn. |
Segments Covered: |
By Type |
|
|
By Test |
|
||
By Application |
|
||
By End-Users |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Frequently Asked Questions :
The forecast period in the Pulmonary Function Testing Systems Market research report is 2024-2032.
MGC Diagnostics Corporation (US), Morgan Scientific Inc. (US), Omron Healthcare Inc (Japan), Cosmed Srl (Italy), Ganshorn Medizin Electronic (Germany), ndd Medizintechnik AG (Switzerland), Schiller AG (Switzerland), Vyaire Medical, Inc (US), Minato Holdings Inc. (Japan), Eco Medics Ag (Switzerland), Chest M.I., Inc (Japan), Koninklijke Philips N.V. (Netherlands), PulmOne Advanced Medical Devices (Israel), KoKo PFT (US), and Other Major Players
The Pulmonary Function Testing Systems Market is segmented into Type, Test, Application, End Users, and region. By Type, the market is categorized into Portable PFT Systems, and Complete PFT Systems. By Test, the market is categorized into Gas Exchange Testing, Oxygen Titration Test, Spirometry, Lung Volume, and Others. By Application, the market is categorized into Restrictive Lung Disease, Chronic Obstructive Pulmonary Disease, Asthma, and Others. By End Users, the market is categorized into Hospitals, Clinical Laboratories, Diagnostics Laboratories, Other. By region, it is analyzed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain, etc.), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
Pulmonary function tests are non-invasive tests that determine how well the lungs work. The tests measure lung volume, gas exchange, and rates of flow. This test helps physicians and healthcare workers to diagnose and decide the treatment of lung disorders. Lungs perform the function of the pulmonary. This involves breathing in air through the nasal passages leading to the lungs and taking in oxygen from the blood that travels to other parts of the body and exhaling carbon dioxide as waste through the nasal passages.
Pulmonary Function Testing Systems Market Size Was Valued at USD 141.8 Million in 2023, and is Projected to Reach USD 282.99 Million by 2032, Growing at a CAGR of 7.98% From 2024-2032.